Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of

Chirine Parsai1, Bart Bijnens, George Ross Sutherland

  • 1Department of Cardiology, St George's Hospital, Blackshaw Road, SW17 0QT London, UK. chirineparsai@hotmail.com

European Heart Journal
|November 14, 2008
PubMed

Insights

Cardiac resynchronization therapy (CRT) response depends on multiple factors, not just left ventricular dyssynchrony. Identifying and correcting these correctable mechanisms improves patient outcomes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Current echocardiographic methods primarily assess left ventricular dyssynchrony (LV DYS) as a sole predictor for cardiac resynchronization therapy (CRT) response.
  • This study challenges that notion, hypothesizing that multiple correctable factors dictate CRT efficacy.

Purpose of the Study:

  • To investigate whether multiple independent mechanisms, beyond LV DYS, predict response to CRT.
  • To identify specific pathological mechanisms influencing CRT outcomes.

Main Methods:

  • 161 patients undergoing CRT were evaluated pre- and post-therapy using echocardiography.
  • Response was defined by NYHA Class reduction or LV reverse remodeling.
  • Four distinct pathological mechanisms were identified and analyzed for their impact on CRT response.

Main Results:

  • Left ventricular dyssynchrony with septal flash (LV DYS-SF) was observed in 54% of patients, with 100% reverse remodeling upon SF elimination.
  • Other identified mechanisms included short-AV delay (13%), long-AV delay (10%), and exaggerated LV-RV interaction (9%), each showing varying degrees of response.
  • 14% of patients had none of these correctable mechanisms and did not respond to CRT.

Conclusions:

  • CRT response is multifactorial, with LV DYS being only one component.
  • Echocardiographic assessments focusing solely on long-axis DYS measurements underestimate treatment response by failing to identify up to 40% of responders.
Abstract

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...